Patents by Inventor Christian Hanke Harcken

Christian Hanke Harcken has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060030608
    Abstract: Compounds of Formula (I) wherein R1, R2, R3, R4, R5, and R6 are as defined herein for Formula (IA) and Formula (IB), or a tautomer, prodrug, solvate, or salt thereof, pharmaceutical compositions containing such compounds, and methods of modulating estrogen receptor activity in a cell or patient or treating an estrogen receptor-mediated disorder, particularly breast and other cancers, in a patient in need thereof by administering an effective amount of compound of the invention thereto.
    Type: Application
    Filed: May 25, 2005
    Publication date: February 9, 2006
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Richard Nelson, Pingrong Liu, John Proudfoot, Doris Riether, Christian Hanke Harcken, David Thomson
  • Publication number: 20050059714
    Abstract: Compounds of Formula (IA) and Formula (IB) wherein R1, R2, R3, R4, R5, and R6 are as defined herein for Formula (IA) or Formula (IB), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
    Type: Application
    Filed: September 17, 2004
    Publication date: March 17, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Rajashehar Betageri, Thomas Gilmore, Christian Hanke Harcken, Daniel Kuzmich, Hossein Razavi, Doris Riether, David Thomson, Ji Wang